Found: 45
Select item for more details and to access through your institution.
Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer.
- Published in:
- Integrative Cancer Therapies, 2023, v. 22, p. 1, doi. 10.1177/15347354231185122
- By:
- Publication type:
- Article
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 5, p. 1348, doi. 10.1007/s10637-021-01112-7
- By:
- Publication type:
- Article
Genetic Testing in an Ethnically Diverse Cohort of High-Risk Women: A Comparative Analysis of BRCA1 and BRCA2 Mutations in American Families of European and African Ancestry.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 15, p. 1925, doi. 10.1001/jama.294.15.1925
- By:
- Publication type:
- Article
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2349646, doi. 10.1001/jamanetworkopen.2023.49646
- By:
- Publication type:
- Article
The molecular portraits of breast tumors are conserved across microarray platforms.
- Published in:
- BMC Genomics, 2006, v. 7, p. 96, doi. 10.1186/1471-2164-7-96
- By:
- Publication type:
- Article
Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 2, p. 317, doi. 10.1177/1078155217733808
- By:
- Publication type:
- Article
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
- Published in:
- Modern Pathology, 2006, v. 19, n. 2, p. 264, doi. 10.1038/modpathol.3800528
- By:
- Publication type:
- Article
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 2, p. 343, doi. 10.1007/s10549-024-07363-1
- By:
- Publication type:
- Article
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 1, p. 75, doi. 10.1007/s10549-023-06943-x
- By:
- Publication type:
- Article
Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 1, p. 57, doi. 10.1007/s10549-022-06722-0
- By:
- Publication type:
- Article
Clinical trials of immunotherapy in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 1, p. 1, doi. 10.1007/s10549-022-06665-6
- By:
- Publication type:
- Article
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 841, doi. 10.1007/s10549-020-05984-w
- By:
- Publication type:
- Article
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 637, doi. 10.1007/s10549-018-4852-5
- By:
- Publication type:
- Article
First international TNBC conference meeting report.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 407, doi. 10.1007/s10549-018-4692-3
- By:
- Publication type:
- Article
Low PTEN levels and <italic>PIK3CA</italic> mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 731, doi. 10.1007/s10549-017-4533-9
- By:
- Publication type:
- Article
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 1, p. 179, doi. 10.1007/s10549-017-4415-1
- By:
- Publication type:
- Article
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 146, n. 3, p. 557, doi. 10.1007/s10549-014-3039-y
- By:
- Publication type:
- Article
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The impact of site-specific digital histology signatures on deep learning model accuracy and bias.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24698-1
- By:
- Publication type:
- Article
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01627-2
- By:
- Publication type:
- Article
Validation of the RSClin risk calculator in the National Cancer Data Base.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1210, doi. 10.1002/cncr.35163
- By:
- Publication type:
- Article
A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies.
- Published in:
- PLoS Medicine, 2006, v. 3, n. 12, p. 2244, doi. 10.1371/journal.pmed.0030486
- By:
- Publication type:
- Article
Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.
- Published in:
- Telemedicine & e-Health, 2024, v. 30, n. 3, p. 651, doi. 10.1089/tmj.2023.0225
- By:
- Publication type:
- Article
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920974118
- By:
- Publication type:
- Article
Concepts and targets in triple-negative breast cancer: recent results and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 5, p. 351, doi. 10.1177/1758834016657071
- By:
- Publication type:
- Article
Novel Therapies for Triple-Negative Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 799
- By:
- Publication type:
- Article
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 10, p. 1776, doi. 10.1002/cncr.27995
- By:
- Publication type:
- Article
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00244-6
- By:
- Publication type:
- Article
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0130-x
- By:
- Publication type:
- Article
If we build it they will come: targeting the immune response to breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0133-7
- By:
- Publication type:
- Article
Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0074-6
- By:
- Publication type:
- Article
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46961-x
- By:
- Publication type:
- Article
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46961-x
- By:
- Publication type:
- Article
Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 1, p. 75, doi. 10.1245/s10434-014-3948-3
- By:
- Publication type:
- Article
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184436
- By:
- Publication type:
- Article
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 1, p. 145, doi. 10.1007/s10549-013-2528-8
- By:
- Publication type:
- Article
Estrogen receptor α, BRCA1 , and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 111, n. 1, p. 113
- By:
- Publication type:
- Article
Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e233329, doi. 10.1001/jamanetworkopen.2023.3329
- By:
- Publication type:
- Article
Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00536-z
- By:
- Publication type:
- Article
Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00530-5
- By:
- Publication type:
- Article
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.
- Published in:
- 2017
- By:
- Publication type:
- journal article